Methods and compositions for minimally invasive capsular augmentation of canine coxofemoral joints

Abstract

The present technology relates to methods and devices for augmenting the canine coxofemoral joint. In particular, methods for augmenting the capsule of the canine coxofemoral joint are provided. In some embodiments, augmentation can be performed by injecting an implantable device comprising a biodegradable matrix and microparticles into the capsule. In some embodiments, augmentation can be performed by imbricating an implantable device comprising a biodegradable matrix and microparticles at the capsule.

What is claimed is: 
     
         1 . A canine coxofemoral joint augmented with an implantable device, wherein said implantable device comprises collagen and microparticles. 
     
     
         2 . The canine coxofemoral joint of  claim 1 , wherein said collagen comprises bovine collagen. 
     
     
         3 . The canine coxofemoral joint of  claim 1 , wherein said microparticles are substantially spherical with a diameter less than 200 μm. 
     
     
         4 . The canine coxofemoral joint of  claim 3 , wherein said microparticles are substantially spherical with a diameter less than 100 μm. 
     
     
         5 . The canine coxofemoral joint of  claim 1 , wherein said implantable device further comprises a bioactive agent. 
     
     
         6 . The canine coxofemoral joint of  claim 5 , wherein said bioactive agent comprises an agent selected from the group consisting of a local anesthetic, non-steroidal anti-inflammatory drug, antibiotic, and antineoplastic agent. 
     
     
         7 . The canine coxofemoral joint of  claim 5 , wherein said bioactive agent comprises lidocaine.